Clinical management innovations such as the introduction of a nurse-led implementation of an intravenous insulin protocol showed a significantly reduced length of stay (4.9 days) in addition to improved target glucose range and reduced hyperglycaemia and hypoglycaemia events (43). This evidence concerns the gene INS and Hyperglycemia.